Poniard Pharmaceuticals, Inc.

PARD · OTC
Analyze with AI
9/30/2011
6/30/2011
3/31/2011
12/31/2010
Assets
Cash & Equivalents$1,984$3,692$5,472$1,284
Short-Term Investments$0$0$0$3,046
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$268$502$637$887
Total Curr. Assets$2,252$4,194$6,109$5,217
Property Plant & Equip (Net)$18$25$37$49
Goodwill$0$0$0$0
Intangibles$5,466$5,770$6,073$6,377
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$5,484$5,795$6,110$6,426
Other Assets$0$0$0$0
Total Assets$7,736$9,989$12,219$11,643
Liabilities
Payables$1,483$1,161$291$392
Short-Term Debt$0$0$0$0
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$1,496$926$993$1,224
Total Curr. Liab.$2,979$2,087$1,284$1,616
LT Debt$1,640$1,618$1,596$1,574
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,640$1,618$1,596$1,574
Other Liabilities$0$0$0$0
Cap. Leases$1,640$1,618$1,596$1,574
Total Liabilities$4,619$3,705$2,880$3,190
Equity
Pref Stock$2$2$2$2
Common Stock$1,199$1,197$1,182$971
Retained Earnings-$449,962-$446,143-$442,237-$438,943
AOCI$0$0$0$8
Other Equity$451,878$451,228$450,392$446,415
Total Equity$3,117$6,284$9,339$8,453
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$7,736$9,989$12,219$11,643
Net Debt-$344-$2,074-$3,876$290